Sort
85,873 grants matching “alzheimers”
Air Pollution-Derived Iron Exposure, Poverty-Related Stress, and Alzheimer's Disease Risk
$1,625,947Marissa Sobolewski Terry · University Of Rochester · RF1 · FY2024 · NS
Priming the proteasome to protect against aging and Alzheimer's disease
$1,625,919Xuejun Wang · University Of South Dakota · RF1 · FY2022 · AG
Roles of the glycogen synthase kinase 3 alpha isoform in Alzheimers disease pathophysiology
$1,625,487Tao Ma · Wake Forest University Health Sciences · RF1 · FY2023 · AG
Alzheimer variants: Propagation of shared functional changes across cellular networks
$1,625,206Philip L De Jager · Columbia University Health Sciences · U01 · FY2022 · AG
Degenerative and Dementing Diseases of Aging
$1,625,072Stanley B Prusiner · University Of California, San Francisco · P01 · FY2012 · AG
A Pragmatic Trial of the UCSF Brain Health Assessment for the Detection of Cognitive Impairment in Primary Care
$1,624,115Katherine Laurel Possin · University Of California, San Francisco · U01 · FY2022 · NS
Locus Coeruleus Imaging Markers in Preclinical Alzheimers disease, Cerebrovascular Disease and Cognitive Decline
$1,623,978Daniel A Nation · University Of California-Irvine · R01 · FY2023 · AG
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
$1,623,635Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2020 · AG
Characterizing Alzheimer's Amyloid-beta Oligomer Structures by Solid-State NMR and Cryo-Electron Microscopy
$1,623,119Anant Krishna Paravastu · Georgia Institute Of Technology · RF1 · FY2022 · AG
MULTICENTER VITAMIN E TRIAL-PERSONS WITH DOWN SYNDROME
$1,622,839Institute For Basic Res In Dev Disabil · R01 · FY2003 · AG
NEUROPATHOLOGY
$1,622,358Daniel W McKeel · Washington University · P50 · FY2008 · AG
Multi-omic functional assessment of novel AD variants using high-throughput and single-cell technologies
$1,622,284Thomas J Montine · Stanford University · U01 · FY2025 · AG
Main Administrative Core
$1,622,133Anne M Murray · Hennepin Healthcare Research Institute · U19 · FY2020 · AG
MECHANISMS UNDERLYING MICROGLIA DYSFUNCTION DURING NEURODEGENERATION
$1,622,124Elizabeta Gjoneska · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Adult Changes in Thought (ACT) Research Program Core F: Data and Analysis Core
$1,622,000Rod Walker · Kaiser Foundation Research Institute · U19 · FY2023 · AG
Understanding the impact of Clusterin on the oligodendrocyte lineage in AD
$1,621,535Alban P Gaultier · University Of Virginia · RF1 · FY2022 · AG
Calcium Regulation in Brain Aging and Alzheimer's Disease
$1,621,491Philip W. Landfield · University Of Kentucky · P01 · FY2008 · AG
TREM2 IN MICROGLIA BIOLOGY AND ALZHEIMER'S DISEASE
$1,621,044Marco Colonna · Washington University · RF1 · FY2021 · AG
ANTECEDENT BIOMARKERS FOR AD: THE ADULT CHILDREN STUDY
$1,620,871John Morris · Washington University · P01 · FY2009 · AG
Mechanisms of Inorganic Carcinogenesis
$1,620,499Michael Waalkes · Basic Sciences · Z01 · FY2007 · CA
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD
$1,619,858Rima F Kaddurah-Daouk · Duke University · U01 · FY2021 · AG
CENTER FOR CAM RESEARCH IN AGING
$1,619,516Columbia University Health Sciences · P50 · FY2001 · AT
National Resource for Mass Spectrom of Biological Macromolecules
$1,619,191Brian T Chait · Rockefeller University · P41 · FY2016 · GM
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease
$1,619,042Allan I Levey · Emory University · U01 · FY2018 · AG
Cellular Cofactors, Neuronal Stress & Rescue, Aging & Alzheimer Disease
$1,618,644Shi Du Yan · Columbia University Health Sciences · P01 · FY2008 · AG